BIO-KEY INTERNATIONAL ($BKYI) posted quarterly earnings results for Q3 2026 on Friday, November 13th. The company reported earnings of -$4.01 per share, missing estimates of -$0.71 by $3.30. The company also reported revenue of $1,480,000, missing estimates of $2,448,000 by $-968,000.
You can see Quiver Quantitative's $BKYI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIO-KEY INTERNATIONAL Hedge Fund Activity
We have seen 5 institutional investors add shares of BIO-KEY INTERNATIONAL stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITIGROUP INC removed 50,349 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $227,073
- STONEX GROUP INC. added 31,830 shares (+inf%) to their portfolio in Q3 2026, for an estimated $89,124
- GEODE CAPITAL MANAGEMENT, LLC removed 29,543 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $133,238
- VIRTU FINANCIAL LLC removed 2,071 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $9,340
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 1,719 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,752
- UBS GROUP AG added 759 shares (+inf%) to their portfolio in Q3 2026, for an estimated $2,125
- MORGAN STANLEY removed 200 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $902
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.